Olanzapine stimulates proliferation but inhibits differentiation in rat oligodendrocyte precursor cell cultures

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 8, 2011, Pages 1950-1956

  Kimoto, Sohei ^a   Okuda, Aya ^a,b   Toritsuka, Michihiro ^a   Yamauchi, Takahira ^a   Makinodan, Manabu ^a   Okuda, Hiroaki ^a   Tatsumi, Kouko ^a   Nakamura, Yu ^b   Wanaka, Akio ^a   Kishimoto, Toshifumi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

ERK; Olanzapine; Oligodendrocyte precursor cell; Schizophrenia

Indexed keywords

HALOPERIDOL; MITOGEN ACTIVATED PROTEIN KINASE; MYELIN BASIC PROTEIN; OLANZAPINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; IN VITRO STUDY; NEURAL STEM CELL; NEWBORN; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; OPTIC NERVE; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BENZODIAZEPINES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; HALOPERIDOL; NEURAL STEM CELLS; OLIGODENDROGLIA; RATS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS;

EID: 82455199166     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.07.011     Document Type: Article

References (48)

1. Ahmed M.R., Gurevich V.V., Dalby K.N., Benovic J.L., Gurevich E.V. Haloperidol and clozapine differentially affect the expression of arrestins, receptor kinases, and extracellular signal-regulated kinase activation. J Pharmacol Exp Ther 2008, 325:276-283.
2. Baron W., Metz B., Bansal R., Hoekstra D., de Vries H. PDGF and FGF-2 signaling in oligodendrocyte progenitor cells: regulation of proliferation and differentiation by multiple intracellular signaling pathways. Mol Cell Neurosci 2000, 15:314-329.
3. Bartzokis G., Lu P.H., Nuechterlein K.H., Gitlin M., Doi C., Edwards N., Lieu C., Altshuler L.L., Mintz J. Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophr Res 2007, 93:13-22.
4. Bartzokis G., Lu P.H., Stewart S.B., Oluwadara B., Lucas A.J., Pantages J., Pratt E., Sherin J.E., Altshuler L.L., Mintz J., Gitlin M.J., Subotnik K.L., Nuechterlein K.H. In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia. Schizophr Res 2009, 113:322-331.
5. Bhat N.R., Zhang P. Activation of mitogen-activated protein kinases in oligodendrocytes. J Neurochem 1996, 66:1986-1994.
6. Bhat N.R., Zhang P., Mohanty S.B. p38 MAP kinase regulation of oligodendrocyte differentiation with CREB as a potential target. Neurochem Res 2007, 32:293-302.
7. Brambilla P., Bellani M., Yeh P.H., Soares J.C. Myelination in bipolar patients and the effects of mood stabilizers on brain anatomy. Curr Pharm Des 2009, 15:2632-2636.
8. Byne W., Kidkardnee S., Tatusov A., Yiannoulos G., Buchsbaum M.S., Haroutunian V. Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus. Schizophr Res 2006, 85:245-253.
9. Chang A., Nishiyama A., Peterson J., Prineas J., Trapp B.D. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 2000, 20:6404-6412.
10. Colognato H., Baron W., Avellana-Adalid V., Relvas J.B., Baron-Van Evercooren A., Georges-Labouesse E., ffrench-Constant C. CNS integrins switch growth factor signalling to promote target-dependent survival. Nat Cell Biol 2002, 4:833-841.
11. Cui Q.L., Almazan G. IGF-I-induced oligodendrocyte progenitor proliferation requires PI3K/Akt, MEK/ERK, and Src-like tyrosine kinases. J Neurochem 2007, 100:1480-1493.
12. Dawson M.R., Polito A., Levine J.M., Reynolds R. NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci 2003, 24:476-488.
13. Fields R.D. White matter in learning, cognition and psychiatric disorders. Trends Neurosci 2008, 31:361-370.
14. Franklin R.J. Why does remyelination fail in multiple sclerosis?. Nat Rev Neurosci 2002, 3:705-714.
15. Garver D.L., Holcomb J.A., Christensen J.D. Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia. Int J Neuropsychopharmacol 2008, 11:49-61.
16. Gensert J.M., Goldman J.E. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 1997, 19:197-203.
17. Georgieva L., Moskvina V., Peirce T., Norton N., Bray N.J., Jones L., Holmans P., Macgregor S., Zammit S., Wilkinson J., Williams H., Nikolov I., Williams N., Ivanov D., Davis K.L., Haroutunian V., Buxbaum J.D., Craddock N., Kirov G., Owen M.J., O'Donovan M.C. Convergent evidence that oligodendrocyte lineage transcription factor 2 OLIG2 and interacting genes influence susceptibility to schizophrenia. Proc Natl Acad Sci USA 2006, 103:12469-12474.
18. Ho B.C., Andreasen N.C., Ziebell S., Pierson R., Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 2011, 68:128-137.
19. Hof P.R., Haroutunian V., Copland C., Davis K.L., Buxbaum J.D. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem Res 2002, 27:1193-1200.
20. Hof P.R., Haroutunian V., Friedrich V.L., Byne W., Buitron C., Perl D.P., Davis K.L. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 2003, 53:1075-1085.
21. Horner P.J., Power A.E., Kempermann G., Kuhn H.G., Palmer T.D., Winkler J., Thal L.J., Gage F.H. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci 2000, 20:2218-2228.
22. Islam M.S., Tatsumi K., Okuda H., Shiosaka S., Wanaka A. Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions. Neurochem Int 2009, 54:192-198.
23. Keirstead H.S., Levine J.M., Blakemore W.F. Response of the oligodendrocyte progenitor cell population defined by NG2 labelling to demyelination of the adult spinal cord. Glia 1998, 22:161-170.
24. Kerns D., Vong G.S., Barley K., Dracheva S., Katsel P., Casaccia P., Haroutunian V., Byne W. Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophrenia. Schizophr Res 2010, 120:150-158.
25. Kinon B.J., Lieberman J.A. Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology Berl 1996, 124:2-34.
26. Kodama M., Fujioka T., Duman R.S. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry 2004, 56:570-580.
27. Konopaske G.T., Dorph-Petersen K.A., Sweet R.A., Pierri J.N., Zhang W., Sampson A.R., Lewis D.A. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry 2008, 63:759-765.
28. Levine J.M., Reynolds R. Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination. Exp Neurol 1999, 160:333-347.
29. Levine J.M., Reynolds R., Fawcett J.W. The oligodendrocyte precursor cell in health and disease. Trends Neurosci 2001, 24:39-47.
30. Levison S.W., Young G.M., Goldman J.E. Cycling cells in the adult rat neocortex preferentially generate oligodendroglia. J Neurosci Res 1999, 57:435-446.
31. Makinodan M., Tatsumi K., Okuda H., Manabe T., Yamauchi T., Noriyama Y., Kishimoto T., Wanaka A. Lysophosphatidylcholine induces delayed myelination in the juvenile ventral hippocampus and behavioral alterations in adulthood. Neurochem Int 2008, 53:374-381.
32. Makinodan M., Yamauchi T., Tatsumi K., Okuda H., Takeda T., Kiuchi K., Sadamatsu M., Wanaka A., Kishimoto T. Demyelination in the juvenile period, but not in adulthood, leads to long-lasting cognitive impairment and deficient social interaction in mice. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:978-985.
33. Nishiyama A., Chang A., Trapp B.D. NG2+ glial cells: a novel glial cell population in the adult brain. J Neuropathol Exp Neurol 1999, 58:1113-1124.
34. Niu J., Mei F., Li N., Wang H., Li X., Kong J., Xiao L. Haloperidol promotes proliferation but inhibits differentiation in rat oligodendrocyte progenitor cell cultures. Biochem Cell Biol 2010, 88:611-620.
35. Okugawa G., Nobuhara K., Takase K., Saito Y., Yoshimura M., Kinoshita T. Olanzapine increases grey and white matter volumes in the caudate nucleus of patients with schizophrenia. Neuropsychobiology 2007, 55:43-46.
36. Rivers L.E., Young K.M., Rizzi M., Jamen F., Psachoulia K., Wade A., Kessaris N., Richardson W.D. PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nat Neurosci 2008, 11:1392-1401.
37. Stariha R.L., Kim S.U. Mitogen-activated protein kinase signalling in oligodendrocytes: a comparison of primary cultures and CG-4. Int J Dev Neurosci 2001, 19:427-437.
38. Takahashi N., Sakurai T., Davis K.L., Buxbaum J.D. Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Prog Neurobiol 2011, 93:13-24.
39. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., Starkey M., Webster M.J., Yolken R.H., Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362:798-805.
40. Watanabe M., Toyama Y., Nishiyama A. Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. J Neurosci Res 2002, 69:826-836.
41. Watkins T.A., Emery B., Mulinyawe S., Barres B.A. Distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating CNS coculture system. Neuron 2008, 60:555-569.
42. Wexler B.E., Zhu H., Bell M.D., Nicholls S.S., Fulbright R.K., Gore J.C., Colibazzi T., Amat J., Bansal R., Peterson B.S. Neuropsychological near normality and brain structure abnormality in schizophrenia. Am J Psychiatry 2009, 166:189-195.
43. Windrem M.S., Nunes M.C., Rashbaum W.K., Schwartz T.H., Goodman R.A., McKhann G., Roy N.S., Goldman S.A. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 2004, 10:93-97.
44. Xiao L., Xu H., Zhang Y., Wei Z., He J., Jiang W., Li X., Dyck L.E., Devon R.M., Deng Y., Li X.M. Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. Mol Psychiatry 2008, 13:697-708.
45. Yamauchi T., Tatsumi K., Makinodan M., Kimoto S., Toritsuka M., Okuda H., Kishimoto T., Wanaka A. Olanzapine increases cell mitotic activity and oligodendrocyte-lineage cells in the hypothalamus. Neurochem Int 2010, 57:565-571.
46. Younes-Rapozo V., Felgueiras L.O., Viana N.L., Fierro I.M., Barja-Fidalgo C., Manhaes A.C., Barradas P.C. A role for the MAPK/ERK pathway in oligodendroglial differentiation in vitro: stage specific effects on cell branching. Int J Dev Neurosci 2009, 27:757-768.
47. Zhang J., Li Y., Zheng X., Gao Q., Liu Z., Qu R., Borneman J., Elias S.B., Chopp M. Bone marrow stromal cells protect oligodendrocytes from oxygen-glucose deprivation injury. J Neurosci Res 2008, 86:1501-1510.
48. Zhang Y., Xu H., Jiang W., Xiao L., Yan B., He J., Wang Y., Bi X., Li X., Kong J., Li X.M. Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse. Schizophr Res 2008, 106:182-191.